Mitsui Link Lab Kasai | List of residents' interviews | Mitsui’s Lab & Office

EN
JP

Startup companies and CRO ※In addition, from entry into different industries,
A wide variety of innovation players in the field of life science.

Here is an interview with the residents.

※CRO is an abbreviation of Contract Research Organization (CRO) and is a company that provides support for part of the work related to clinical trials (clinical trials) at the drug development stage and post-market clinical trials of pharmaceuticals.

Bio-Pharmaceuticals and Regenerative Medicine Mitsui Link Lab Kasai

Dizyme Co., Ltd.

[Interview with Mr. Ken Izumi Wataru and Ken Izumi, Inc.] "The facilities of Kasai Lab are wonderful and are often praised by visitors. I would like to continue to actively utilize it."

Digizyme Co., Ltd. is a start-up originating from Tokyo Institute of Technology, which aims to develop technologies that efficiently design enzymes suitable for industrial applications, and quickly lead to mass production. This time, we asked Naoto Watarai (Co-founder, Representative Director and CEO) and Ken Izumi (Executive Officer, COO) about the history of the company, the initiatives they are currently taking on challenges, and the future vision they would like to realize at Mitsui Link Lab Kasai.

See more details.
Bio-Pharmaceuticals and Regenerative Medicine Mitsui Link Lab Kasai

U-Factor Co., Ltd.

[Interview with U-Factor Keigo Hori, Kento Otake] "Mitsui Link Lab Kasai's lab will continue to play a leading role in all our R&D programs."

U-Factor Co., Ltd. is a startup that explores new possibilities for regenerative medicine for intractable neurological diseases by using stem cell culture supernatant fluid created from tooth cord stem cells. The success of the company's challenge will create an inexpensive, mass-produced regenerative medicine that overturns conventional common sense. This time, we asked Keigo Hori (Director COO) and Kento Otake (facility manager) about the history of the company's birth, the initiatives they are taking on challenges, and the future vision they want to realize.

See more details.
Bio-Pharmaceuticals and Regenerative Medicine Mitsui Link Lab Kasai

TORII PHARMACEUTICAL Co., Ltd.

[Torii Pharmaceutical Co., Ltd. Masayo Doi and Hiroyuki Miyazaki] Through the harmony of tenants, we want to create innovations that are different from major companies in Mitsui Link Lab Kasai.

Torii Pharmaceutical Co., Ltd. is a pharmaceutical company established in 1921, headquartered in Nihonbashi-Honmachi, Chuo-ku, Tokyo. Mitsui Link Lab Kasai is conducting research to maximize the value of its own products. We interviewed Mr. Doi and Mr. Miyazaki, Innovation Research Department, Value Creation Group.

See more details.
Bio-Pharmaceuticals and Regenerative Medicine Mitsui Link Lab Kasai

Standard Biotools Co., Ltd.

[Interview with Shinichi Inamori, Standard Biotools Co., Ltd.] "They understands the issues peculiar to life science companies and respond as usual. I think that's the real charm of Mitsui Link Labour."

Standard Biotools Co., Ltd. is a research equipment and reagent sales company headquartered in San Francisco. Currently, he has an office in Nihonbashi Kodenmacho, and has also opened its own lab in Mitsui Link Lab Kasai. We operate the masssite meter "CyTOF", one of the company's leading products, and as a part of a demonstration to help them learn about the company's technical capabilities. We have spoken to Mr. Inamori, President and CEO.

See more details.

Contact

Those who are looking for brochures

Requests for data

Those who want to know about previews and rents

Contact